Assess the clinical safety and feasibility of MultiPulse Therapy (MPT) electrical stimulation waveform sequence in terminating paroxysmal and persistent atrial fibrillation.
|Effective start/end date||2/1/22 → 8/31/22|
- Cardialen, Inc. (SBIR2020-02//5R44HL154937-02)
- National Heart, Lung, and Blood Institute (SBIR2020-02//5R44HL154937-02)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.